In the blog of Transparency in Veterinaria Digital, we have been reporting during the last few weeks what in our opinion constitute severe deficiencies in the Spanish Agency of the Medicament.

From the Deputy Director and Director of the Agency who offer their services in Universities to carry out studies in order to obtain the registration of specialities in the same Agency, to functional alterations that permit to suppose the existence of a supposed plot to oblige the companies to use their services through delays in processing and /or issuing their negative resolutions if they use the services offered by the Agency.

At this situation, it can be added the lack of guarantees that suppose the failure to comply with the Art. 3.4. of the law 29/2006 on July 26th, about guarantees and rational use of medicaments and sanitary products which was published in nº 178 of the Official State Bulletin (BOE) on July 27th, where it can be read the following:

“Art. 3. Guarantees of independency.

4. The membership to committees of the Spanish Agency of the Medicament and Sanitary Products, to Ethical Committees of Clinical Investigation or to committees or advisory organs established by the Sanitary Administrations of the autonomous region, will be incompatible with any type of interest derived from the manufacturing or sale of medicaments and sanitary products.”

With all the information mentioned above, can anybody explain why some members of Veterindustria were in the Committee for Evaluation and Availability of veterinary medicaments of the Spanish Agency of the Medicament?

From Veterinaria Digital, we wonder how come the presidency can publish some guarantees of independency for the members of the committees, and the Ministry of Health can make appointments allegedly incompatible because of its link to any kind of interest derived from the manufacturing and sale of medicaments and veterinary products.